Clinical Trial Update: Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating low-dose naltrexone for painful diabetic neuropathy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: RECRUITING